SCI时时刷

search
+
Correction: A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
All authors have requested a correction to include the middle initials for all authors.Neal Shore1,*, Emmanuel Antonarakis...
Prostatectomy in oligometastatic prostate cancer: a call for high-quality evidence
The systematic review by Saouli et al. investigates the role of radical prostatectomy (RP) in managing oligometastatic pro...
Transrectal prostate biopsy: easy, effective and safe
European Association of Urology. Prostate Cancer Guidelines. 2023.Wei JT, Barocas D, Carlsson S, Coakley F, Eggener S, Etz...
Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH
Ejaculation sparing of classic and minimally invasive surgical treatments of LUTS/BPH
The surgical landscape for Lower Urinary Tract Symptoms (LUTS) and Benign Prostatic Hyperplasia (BPH) has evolved with the...
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort
Addressing racial disparities in prostate cancer pathology prediction models: external validation and comparison of four models of pathological outcome prediction before radical prostatectomy in the multiethnic SEARCH cohort
Certain widely used pathological outcome prediction models that were developed in tertiary centers tend to overpredict out...
Propensity score-matched evaluation of palliative transurethral resection and holmium laser enucleation of the prostate for bladder outlet obstruction in patients with prostate cancer
While transurethral resection of the prostate (TURP) is the standard-of-care, Holmium laser enucleation of the prostate (H...
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials
Role of enzalutamide in primary and recurrent non-metastatic hormone sensitive prostate cancer: a systematic review of prospective clinical trials
Enzalutamide, a second-generation androgen receptor inhibitor, is indicated for the treatment of metastatic disease, as we...
Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies
Prostate cancer detection and complications of MRI-targeted prostate biopsy using cognitive registration, software-assisted image fusion or in-bore guidance: a systematic review and meta-analysis of comparative studies
Three primary strategies for MRI-targeted biopsies (TB) are available: Cognitive TB (COG-TB), MRI-US Fusion TB (FUS-TB), a...
The times have changed. Let the urologists change!
In this special collection, the focus is on new physiopathological hypotheses and technological innov...
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
Emerging racial disparities among Medicare beneficiaries and Veterans with metastatic castration-sensitive prostate cancer
Previous studies have shown that Black men receive worse prostate cancer care than White men. This has not been explored i...
Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer
Targeting the tumor microenvironment, a new therapeutic approach for prostate cancer
A growing number of studies have shown that in addition to adaptive immune cells such as CD8 + T cells and CD4...
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer
The diagnostic yield of the Meares & Stamey test can be significantly improved by symptom-based patient selection and the experience of the test performer
Even if Meares-Stamey 4-glass (M&S) test is regarded a decisive tool for diagnosing prostatitis its use is only ra...
The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016
The association of patient and disease characteristics with the overtreatment of low-risk prostate cancer from 2010 to 2016
Although active surveillance is the preferred management for low-risk prostate cancer (PCa), some men remain at risk of ov...
A randomized controlled trial evaluating low-intensity shockwave therapy for treatment of persistent storage symptoms following transurethral surgery for benign prostatic obstruction
A randomized controlled trial evaluating low-intensity shockwave therapy for treatment of persistent storage symptoms following transurethral surgery for benign prostatic obstruction
Low-intensity shockwave therapy (Li-SWT) can improve bladder function through enhancement of angiogenesis and nerve regene...
Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
Real-world overall survival with abiraterone acetate versus enzalutamide in chemotherapy-naïve patients with metastatic castration-resistant prostate cancer
There are no large head-to-head phase 3 clinical trials comparing overall survival (OS) for abiraterone and enzalutamide. ...
Is extended pelvic lymph node dissection REALLY required for staging of prostate cancer in the PSMA-PET era?
An extended pelvic lymph node dissection (ePLND) at time of radical prostatectomy remains a recommend...
Extraperitoneal robot assisted laparoscopic prostatectomy with Versius system: single centre experience
Extraperitoneal robot assisted laparoscopic prostatectomy with Versius system: single centre experience
Versius Surgical System (CMR Surgical, Cambridge, UK) is a novel tele-operated robotic surgical system designed to assist ...
TRexit is going one step further
Grummet J, Gorin MA, Popert R, O’Brien T, Lamb AD, Hadaschik B, et al. “TREXIT 2020”: why the time to abandon transrectal ...
Low-dose-rate brachytherapy as a primary treatment for localised and locally advanced prostate cancer: a systematic review of economic evaluations
Low-dose-rate brachytherapy as a primary treatment for localised and locally advanced prostate cancer: a systematic review of economic evaluations
This study supports a value-based approach to prostate cancer (PCa) treatment by systematically reviewing economic evaluat...
MDT perspective: intraductal carcinoma of the prostate: implication for diagnosis and treatment
Zhao J, Xu N, Zhu S, Nie L, Zhang M, Zheng L, et al. Genomic and evolutionary characterization of concurrent intraductal c...
A multidisciplinary approach to address unmet needs in the management of patients with non-metastatic castration-resistant prostate cancer
With the availability of second-generation androgen receptor inhibitors (SGARIs), the treatment landscape has changed dram...
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel
Markers of bone metabolism and overall survival in men with bone-metastatic hormone sensitive prostate cancer (HSPC): A subset analysis of SWOG S1216, a phase III trial of androgen deprivation with or without orteronel
Circulating biomarkers of bone metabolism are significantly associated with overall survival (OS) in men with advanced pro...
Genomic attributes of prostate cancer across primary and metastatic noncastrate and castrate resistant disease states: a next generation sequencing study of 183 patients
Primary prostatic adenocarcinoma (pPC) undergoes genomic evolution secondary to therapy-related selection pressures as it ...
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes
Natural Killer Cell Infiltration in Prostate Cancers Predict Improved Patient Outcomes
Natural killer (NK) cells are non-antigen specific innate immune cells that can be redirected to targets of interest using...
Hyperglycemia and microRNAs in prostate cancer
Hyperglycemia and microRNAs in prostate cancer
Hyperglycemia can promote the development of prostate cancer (PCa). Differential expression levels of miRNAs between PCa p...
Variation in communication of side effects in prostate cancer treatment consultations
Variation in communication of side effects in prostate cancer treatment consultations
Effective communication of treatment side effects (SE) is critical for shared decision-making (SDM) in localized prostate ...
Democratizing robotic prostatectomy: navigating from novel platforms, telesurgery, and telementoring
Several novel robotic platforms have recently gained clearance for clinical use, breaking the two-dec...
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer
Updated 5-year results for short course abiraterone acetate and LHRH agonist for unfavorable intermediate and favorable high-risk prostate cancer
Combined androgen deprivation therapy (ADT) and radiotherapy (RT) improves outcomes for intermediate and high-risk prostat...
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration
Clinical implications of AR alterations in advanced prostate cancer: a multi-institutional collaboration
AR gene alterations can develop in response to pressure of testosterone suppression and androgen receptor targeting agents...
High-intensity interval training versus moderate-intensity continuous training for localized prostate cancer under active surveillance: a systematic review and network meta-analysis
High-intensity interval training versus moderate-intensity continuous training for localized prostate cancer under active surveillance: a systematic review and network meta-analysis
High-intensity interval training (HIIT) and moderate-intensity continuous training (MICT) have been increasingly adopted f...
阅读更多
format_indent_increase